Economic Burden of Hepatitis C Virus Infection in Different Stages of Disease: A Report From Southern Iran

Authors Information
Article Notes and Dates
To Cite : Zare F, Fattahi M R, Sepehrimanesh M, Safarpour A R. Economic Burden of Hepatitis C Virus Infection in Different Stages of Disease: A Report From Southern Iran, Hepat Mon. 2016 ;16(4):e32654. doi: 10.5812/hepatmon.32654.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Brown RJ, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl. 2003; 9(11)-3[DOI][PubMed]
  • 2. Alavian SM. We Need a New National Approach to Control Hepatitis C: It is Becoming too Late. Hepat Mon. 2008; 8(3): 165-9
  • 3. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology. 1997; 26(3): 521-6[DOI][PubMed]
  • 4. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341(8): 556-62[DOI][PubMed]
  • 5. Malekzadeh R, Khatibian M, Rezvan H. Viral hepatitis in the world and Iran; epidemiology, diagnosis, prevention and treatment. Sci J Med Council Islam Republic Iran. 1997; 15: 183-200
  • 6. Shamsdin SA, Sepehrimanesh M, Pezeshki B, Nejabat M. Seroprevalence of Hepatitis B and C in Patients With Hemophilia: A Single-Centre Descriptive Study. Shiraz E Med J. 2015; 16(7)[DOI]
  • 7. Alavian SM, Adibi P, Zali MR. Hepatitis C virus in Iran: Epidemiology of an emerging infection. Arch Iran Med. 2005; 8(2): 84-90
  • 8. Gabriella De Carli M, Puro V, Ippolito G. Risk of hepatitis C virus transmission following per-cutaneous exposure in healthcare workers. Infection. 2003; 31(5)
  • 9. Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy. 2007; 18(5): 352-8[DOI][PubMed]
  • 10. Alavian SM, Fallahian F, Lankarani KB. Comparison of seroepidemiology and transmission modes of viral hepatitis C in Iran and Pakistan. Hepat Mon. 2008; 8(1): 51-9
  • 11. Jadoul M, Cornu C, van Ypersele de Strihou C. Universal precautions prevent hepatitis C virus transmission: a 54 month follow-up of the Belgian Multicenter Study. The Universitaires Cliniques St-Luc (UCL) Collaborative Group. Kidney Int. 1998; 53(4): 1022-5[DOI][PubMed]
  • 12. Regev A, Schiff ER. Viral hepatitis. Curr Opin Gastroenterol. 1999; 15(3): 234-9[PubMed]
  • 13. Mirmomen S, Alavian SM. Treatment of HCV infection in multitransfused thalassemic patients: does liver iron status affect the outcome of response. Hepat Mon. 2005; 5(1): 111-3
  • 14. Fattahi MR, Safarpour A, Sepehrimanesh M, Hosseini Asl SM, Mohamaddoust F. The prevalence of hepatitis C virus infection and its related risk factors among the rural population of fars province, southern iran. Hepat Mon. 2015; 15(2)[DOI][PubMed]
  • 15. Malone DC. Cost-effectiveness analysis of interferon a-2b with ribavirin for chronic hepatitis C infection. Formulary. 2000; 35(8): 681
  • 16. Vrontisi Z, Abrell J, Neuwahl F, Saveyn B, Wagner F. Economic impacts of EU clean air policies assessed in a CGE framework. Environ Sci Policy. 2016; 55: 54-64[DOI]
  • 17. Ong SC, Lim SG, Li SC. How big is the financial burden of hepatitis B to society? A cost-of-illness study of hepatitis B infection in Singapore. J Viral Hepat. 2009; 16(1): 53-63[DOI][PubMed]
  • 18. Merat S, Poustchi H. Hepatitis C in Iran. How extensive of a problem is it? Arch Iran Med. 2012; 15(5): 268[PubMed]
  • 19. Keshavarz K, Kebriaeezadeh A, Alavian SM, Akbari Sari A, Abedin Dorkoosh F, Keshvari M, et al. Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran. Hepat Mon. 2015; 15(4)[DOI]
  • 20. Ashtari S, Vahedi M, Pourhoseingholi MA, Pourhoseingholi A, Safaee A, Moghimi-Dehkordi B, et al. Estimation of average diagnosis and treatment costs of hepatitis C. Gastroenterol Hepatol Bed Bench. 2012; 5(3): 139-45[PubMed]
  • 21. Razavi H, Elkhoury AC, Elbasha E, Estes C, Pasini K, Poynard T, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology. 2013; 57(6): 2164-70[DOI][PubMed]
  • 22. Poret AW, Ozminkowski RJ, Goetzel R, Pew JE, Balent J. Cost burden of illness for hepatitis C patients with employer-sponsored health insurance. Dis Manag. 2002; 5(2): 95-107
  • 23. Kavosi Z, Zare F, Jafari A, Fattahi MR. Economic burden of hepatitis B virus infection in different stages of disease; a report from southern iran. Middle East J Dig Dis. 2014; 6(3): 156-61[PubMed]
  • 24. Varmaghani M, Arab M, Zeraati H. The most important factors that patient choose public or private hospital. 2008;
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check